These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

681 related articles for article (PubMed ID: 24946140)

  • 1. Polypharmacology: challenges and opportunities in drug discovery.
    Anighoro A; Bajorath J; Rastelli G
    J Med Chem; 2014 Oct; 57(19):7874-87. PubMed ID: 24946140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polypharmacology in Drug Discovery: A Review from Systems Pharmacology Perspective.
    Zhang W; Bai Y; Wang Y; Xiao W
    Curr Pharm Des; 2016; 22(21):3171-81. PubMed ID: 26907941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polypharmacology - foe or friend?
    Peters JU
    J Med Chem; 2013 Nov; 56(22):8955-71. PubMed ID: 23919353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GES polypharmacology fingerprints: a novel approach for drug repositioning.
    Pérez-Nueno VI; Karaboga AS; Souchet M; Ritchie DW
    J Chem Inf Model; 2014 Mar; 54(3):720-34. PubMed ID: 24494653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic polypharmacology: from combination therapy to multitargeted drugs.
    de Lera AR; Ganesan A
    Clin Epigenetics; 2016; 8():105. PubMed ID: 27752293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Turning liabilities into opportunities: Off-target based drug repurposing in cancer.
    Palve V; Liao Y; Remsing Rix LL; Rix U
    Semin Cancer Biol; 2021 Jan; 68():209-229. PubMed ID: 32044472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational Multitarget Drug Design.
    Zhang W; Pei J; Lai L
    J Chem Inf Model; 2017 Mar; 57(3):403-412. PubMed ID: 28166637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the efficacy-safety balance of polypharmacology in multi-target drug discovery.
    Ravikumar B; Aittokallio T
    Expert Opin Drug Discov; 2018 Feb; 13(2):179-192. PubMed ID: 29233023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward structure-multiple activity relationships (SMARts) using computational approaches: A polypharmacological perspective.
    López-López E; Medina-Franco JL
    Drug Discov Today; 2024 Jul; 29(7):104046. PubMed ID: 38810721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs Polypharmacology by In Silico Methods: New Opportunities in Drug Discovery.
    Lauria A; Bonsignore R; Bartolotta R; Perricone U; Martorana A; Gentile C
    Curr Pharm Des; 2016; 22(21):3073-81. PubMed ID: 26907944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational polypharmacology: a new paradigm for drug discovery.
    Chaudhari R; Tan Z; Huang B; Zhang S
    Expert Opin Drug Discov; 2017 Mar; 12(3):279-291. PubMed ID: 28067061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of protein conformations for structure-based polypharmacology studies.
    Pinzi L; Caporuscio F; Rastelli G
    Drug Discov Today; 2018 Nov; 23(11):1889-1896. PubMed ID: 30099123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harnessing Polypharmacology with Computer-Aided Drug Design and Systems Biology.
    Wathieu H; Issa NT; Byers SW; Dakshanamurthy S
    Curr Pharm Des; 2016; 22(21):3097-108. PubMed ID: 26907947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polypharmacology of Approved Anticancer Drugs.
    Amelio I; Lisitsa A; Knight RA; Melino G; Antonov AV
    Curr Drug Targets; 2017; 18(5):534-543. PubMed ID: 26926468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polypharmacology: in silico methods of ligand design and development.
    McKie SA
    Future Med Chem; 2016 Apr; 8(5):579-602. PubMed ID: 27105127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polypharmacology in Precision Oncology: Current Applications and Future Prospects.
    Antolin AA; Workman P; Mestres J; Al-Lazikani B
    Curr Pharm Des; 2016; 22(46):6935-6945. PubMed ID: 27669965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Silico Oncology Drug Repositioning and Polypharmacology.
    Cheng F
    Methods Mol Biol; 2019; 1878():243-261. PubMed ID: 30378081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network pharmacology: the next paradigm in drug discovery.
    Hopkins AL
    Nat Chem Biol; 2008 Nov; 4(11):682-90. PubMed ID: 18936753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and Discovery.
    Roy S; Dhaneshwar S; Bhasin B
    Curr Drug Res Rev; 2021; 13(2):101-119. PubMed ID: 33573567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polypharmacology: The science of multi-targeting molecules.
    Kabir A; Muth A
    Pharmacol Res; 2022 Feb; 176():106055. PubMed ID: 34990865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.